Interv Akut Kardiol 2011; 10(5-6): 232-234
Heart vave surgery in combination with pulmonary hypertension
- Kardiochirurgické oddělení Nemocnice České Budějovice, a.s
Pulmonary hypertension is a usual comorbidity of heart valvular diseases indicated for surgery. The Czech guidelines give us an sufficient
information about etiology, classification and patophysiology but dont discuss this problem during cardiac surgery procedures. I would
like to focus on pulmonary hypertension as a risk faktor of cardiac surgery. In this paper will not be discussed a pulmonary endarterectomy
as solution of chronic obstructive process of pulmonary arteries.
Keywords: pulmonary hypertension, cardiac surgery
Published: November 1, 2011 Show citation
References
- Schmid ER, Burki CH, et al. Inhaled nitric oxide vs. intravenous vasodilatators in severe pulmonary hypertension after cardiac surgery. Anest Analg 1999; 89: 1108-1115.
Go to original source... - Solina A, Papp D, et al. A comparison of inhaled nitric oxide and milrinone for treatment of pulmonary hypertension in adult cardiac surgery patiens. J Thoracic and Cardiovascular Anesthesia 2000; 14(1): 12-17. Go to original source...
- Feneck RO, Shery KM, et al. Comparison of the hemodynamic effect of Milrinone with Dobutamine in patiens after cardiac surgery. J Thoracic and Cardiovascular Anesthesia 2001; 15(3): 306-315. Go to original source...
- Ocal A, Kiris I, et al. Efficiency of prostacyclin in the treatment of protamine-mediated right ventricular failure and acute pumonary hypertension. J. Exp. Med. 2005; 207: 51-58. Go to original source...
- Haché M, Denault AY, Belisle S, et al. Inhaled prostacyklin (PGI2) is an effective addition to the treatment of pulmonary hypertension and hypoxia in the operating room and intensive care unit. Can J Anest 2001; 48(9): 924-929. Go to original source...
Go to PubMed... - Haché M, Denault AY, Belisle S, et al. Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery. J Thorac Cardiovasc Surg 2003; 125: 642-649. Go to original source... Go to PubMed...
- Lamarche Y, Malo O, Thorin E, et al. Inhaled but not intravenous milrinone prevents pulmonary endotelial dysfunction after cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005; 130: 83-92. Go to original source... Go to PubMed...
- Lamarche Y, Perrault LP, Maltais S, et al. Prelimitary experience with inhaled milrinone in cardiac surgery. Eur J Cardiothorac Surg, 2007; 31. 1081-1087. Go to original source... Go to PubMed...
- Vincens JJ, Temizer D, Post JR, et al. Long-term outcome of cardiac surgery in patiens with mitral stenosis and severe pulmonary hypertension. Circulation 1995; 92. 137-142. Go to original source... Go to PubMed...
- Salzber SP, Filsoufi F, Anyanwu F, et al. High-risk mitral valve surgery: perioperative hemodynamic optimalisation with Nesiritide. Ann Thorac Surg 2005; 80: 502-506. Go to original source... Go to PubMed...
- Mubeen M, Singh AK, Agarwal SK, et al. Mitral valve replacement in severe pulmonary arterial hypertension. Asian Cardiovasc Thorac Ann 2008; 16: 37-42. Go to original source... Go to PubMed...
- Barbieri A, Bursi F, Grigioni F, et al. Prognosis and terapeutic implications of pulmonary hypertesion complicating degenerative mitral regurgitation due to flail leaflet: A multicenter long-term international study. Eur Heart J Advance Access September, 2010.
- Pai RG, Varadarajan P, Kapoor N, et al. Aortic valve replacement improves survival in severe aortic stenosis associated with severe pulmonary hypertension. Ann Thorac Surg 2007; 84: 80-86. Go to original source... Go to PubMed...
- Tracy GP, Proctor MS, Hizny CS. Reversibility of pulmonary artery hypertension in aortic stenosis after aortic valve replacement. Ann Thorac Surg 199; 50: 89-93.
- Khandhar S, Varadajaran P, Turk R, et al. Survival benfit of aortic valve replacement in patiens with severe aortic regurgitation and pulmonary hypertension. Ann Thorac Surg 2009; 88: 752-757. Go to original source... Go to PubMed...